Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Men continue to have normal life after radiation for prostate cancer

18.07.2005


Men receiving radiation therapy to combat early-stage prostate cancer are still able to achieve an erection and face a low rate of incontinence one year following treatment, according to a new study published in the July 15, 2005 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.



Researchers enrolled 98 men from 24 institutions and set out to gauge the health-related quality of life in patients receiving low-dose rate prostate brachytherapy, a form of internal radiation therapy in which tiny radioactive seeds are implanted directly into the prostate gland to battle the cancer.

Patients were given three separate health-related quality of life questionnaires a total of five times before, during and after undergoing radiation therapy to allow researchers to evaluate what effect their treatment was having on them. The two most important side effects studied were sexual and urinary function.


The study reports that one year after receiving treatment, 78 percent of the men were able to achieve an erection, both with and without assistance. However, nearly 50 percent of the men did experience some loss of sexual function, such as reduced desire, activity and satisfaction as well as fatigue.

Although the overall rate of incontinence was low at 1 percent, some men did have difficulty urinating at the one-year mark. Typically, incontinence increases at the beginning of treatment and is completely gone one year after treatment.

"This is the first multi-institutional study of its kind," said Steven J. Feigenberg, M.D., lead author of the study and a radiation oncologist at Fox Chance Cancer Center in Philadelphia. "This study has provided us with valuable data that will help radiation oncologists better address possible side effects patients may have after receiving seed implants for prostate cancer."

For more information on radiation therapy for prostate cancer, please visit http://www.astro.org/patient/treatment_information/ for a free brochure.

To arrange an interview with Dr. Feigenberg or for a copy of the study "Health-Related Quality of Life in Men Receiving Prostate Brachytherapy on RTOG 98-05," please contact Nick Lashinsky at nickl@astro.org or 1-800-962-7876. ASTRO is the largest radiation oncology society in the world, with more than 8,000 members who specialize in treating patients with radiation therapies. As a leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving socioeconomic healthcare environment.

Beth Bukata | EurekAlert!
Further information:
http://www.astro.org

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nonstop Tranport of Cargo in Nanomachines

Max Planck researchers revel the nano-structure of molecular trains and the reason for smooth transport in cellular antennas.

Moving around, sensing the extracellular environment, and signaling to other cells are important for a cell to function properly. Responsible for those tasks...

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

Sustainable energy supply in developing and emerging countries: What are the needs?

21.11.2018 | Power and Electrical Engineering

Nonstop Tranport of Cargo in Nanomachines

20.11.2018 | Life Sciences

Researchers find social cultures in chimpanzees

20.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>